Safety and Pharmacokinetics of Pravastatin Used for the Prevention of Preeclampsia in High-Risk Pregnant Women: A Pilot Randomized Controlled Trial

BACKGROUND: Preeclampsia complicates approximately 3% to 5% of pregnancies and remains a major cause of maternal and neonatal morbidity and mortality. It shares pathogenic similarities with adult cardiovascular disease as well as many risk factors. Pravastatin, a hydrophilic, 3-hydroxy-3-methyl-glut...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am J Obstet Gynecol
Asıl Yazarlar: Costantine, Maged M., Cleary, Kirsten, Hebert, Mary F., Ahmed, Mahmoud S., Brown, Linda M., Ren, Zhaoxia, Easterling, Thomas R., Haas, David M., Haneline, Laura S., Caritis, Steve N., Venkataramanan, Raman, West, Holly, D’Alton, Mary, Hankins, Gary
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4884459/
https://ncbi.nlm.nih.gov/pubmed/26723196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2015.12.038
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller